FDA reverses course and will review Moderna’s mRNA-based flu shot - The Washington Post
business 2026/02/18 21:49:32

FDA reverses course and will review Moderna’s mRNA-based flu shot - The Washington Post

Source:The Washington Post
Author:Rachel Roubein

Moderna announced that the FDA agreed to review its application for a mRNA-based flu vaccine after it agreed to further study in older adults.